# A Unique Regimen for Treatment of Helicobacter Pylori Infection

> **NCT03491995** · PHASE3 · UNKNOWN · sponsor: **Sherief Abd-Elsalam** · enrollment: 600 (estimated)

## Conditions studied

- Helicobacter Infections

## Interventions

- **DRUG:** Quadruple therapy
- **DRUG:** Classic treatment

## Key facts

- **NCT ID:** NCT03491995
- **Lead sponsor:** Sherief Abd-Elsalam
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-01
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2018-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03491995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03491995, "A Unique Regimen for Treatment of Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03491995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*